Peregrine Pharmaceuticals shares owned by Swiss National Bank
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Swiss National Bank
from 13F filings
Historical chart of Swiss National Bank investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Swiss National Bank
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $809k | 124k | 6.50 |
| 2023-09-30 | $1.3M | 138k | 9.44 |
| 2023-06-30 | $1.9M | 136k | 13.97 |
| 2023-03-31 | $2.5M | 134k | 18.76 |
| 2022-12-31 | $2.1M | 150k | 13.77 |
| 2022-09-30 | $2.8M | 146k | 19.12 |
| 2022-06-30 | $2.2M | 145k | 15.26 |
| 2022-03-31 | $3.0M | 145k | 20.37 |
| 2021-12-31 | $3.9M | 135k | 29.18 |
| 2021-09-30 | $2.9M | 134k | 21.57 |
| 2021-06-30 | $3.4M | 134k | 25.65 |